ARICO', ARIANNA
 Distribuzione geografica
Continente #
NA - Nord America 1.515
EU - Europa 282
AS - Asia 113
Totale 1.910
Nazione #
US - Stati Uniti d'America 1.513
CN - Cina 106
SE - Svezia 81
IT - Italia 80
FI - Finlandia 37
IE - Irlanda 21
DE - Germania 18
GR - Grecia 12
FR - Francia 8
UA - Ucraina 8
GB - Regno Unito 6
PL - Polonia 6
IN - India 3
JP - Giappone 3
NL - Olanda 3
CA - Canada 2
HU - Ungheria 1
RO - Romania 1
TW - Taiwan 1
Totale 1.910
Città #
Fairfield 227
Houston 172
Ann Arbor 152
Woodbridge 150
Chandler 120
Ashburn 89
Cambridge 88
Seattle 85
Wilmington 77
Des Moines 30
Princeton 30
Padova 29
Medford 28
Roxbury 28
Jacksonville 26
Beijing 25
Boardman 24
Guangzhou 22
Nanjing 21
San Diego 21
Dublin 20
Cagliari 12
Helsinki 10
Los Angeles 6
Nanchang 6
Shenyang 5
Hebei 4
Jiaxing 4
Norwalk 4
Tappahannock 4
Changsha 3
Naples 3
Ogden 3
Tianjin 3
Bologna 2
Borås 2
Groningen 2
Jinan 2
Kharkiv 2
Milan 2
North York 2
Pune 2
Rizziconi 2
Shanghai 2
Tokyo 2
Washington 2
Zhengzhou 2
Auburn Hills 1
Boston 1
Bucharest 1
Chicago 1
Dieppe 1
Edinburgh 1
Gunzenhausen 1
Hangzhou 1
Indiana 1
Kunming 1
Kyoto 1
Longwood 1
Nardò 1
Paris 1
Porto 1
Redwood City 1
Salerno 1
San Giorgio Del Sannio 1
San Jose 1
San Nicola 1
Sant'elpidio A Mare 1
Silea 1
Taipei 1
Taizhou 1
Trieste 1
Turin 1
Udine 1
Yellow Springs 1
Totale 1.585
Nome #
Array-based comparative genomic hybridization analysis reveals chromosomal copy number aberrations associated with clinical outcome in canine diffuse large B-cell lymphoma. 119
Canine indolent and aggressive lymphoma: clinical spectrum with histologic correlation 114
DNA methylation profiling reveals common signatures of tumorigenesis and defines epigenetic prognostic subtypes of canine Diffuse Large B-cell Lymphoma 105
Evaluation of tyrosine-kinase receptor c-KIT (c-KIT) mutations, mRNA and protein expression in canine leukemia: Might c-KIT represent a therapeutic target? 100
Platelet-derived Growth Factors and Receptors in Canine Lymphoma. 96
Matrix metalloproteinases and their inhibitors in canine mammary tumors 94
Expression of Matrix Metalloproteinases, Tissue Inhibitors of Metalloproteinases and Vascular Endothelial Growth Factor in Canine Mast Cell Tumours. 90
Minimal residual disease detection by flow cytometry and PARR in lymph node, peripheral blood and bone marrow, following treatment of dogs with diffuse large B-cell lymphoma 90
CD44 in canine leukemia: Analysis of mRNA and protein expression in peripheral blood 90
VEGF and MMP-9: biomarkers for canine lymphoma 89
Evaluation of tyrosine-kinase receptor c-kit mutations, mRNA and protein expression in canine lymphoma: Might c-kit represent a therapeutic target? 87
Chondroitin sulfate proteoglycan-4: a biomarker and a potential immunotherapeutic target for canine malignant melanoma. 77
Matrix metalloproteinases and vascular endothelial growth factor expression in canine leukaemias 77
The role of vascular endothelial growth factor and matrix metalloproteinases in canine lymphoma: in vivo and in vitro study 75
Interaction between tumour and microenvironment - molecular mechanisms of cell migration in canine tumours 75
X-Linked Hereditary Nephropathy in Navasota Dogs: Clinical Pathology, Morphology, and Gene Expression During Disease Progression 68
Evaluation of c-KIT (CD117) mutations, mRNA and protein expression in canine leukemia and lymphoma: might c-KIT represent a therapeutical target? 62
Molecole di adesione e metalloproteasi: indagine sul ruolo di CD44 e MMP-9 nelle neoplasie ematopoietiche canine 57
INTERACTION BETWEEN TUMOUR AND MICROENVIRONMENT - MOLECULAR MECHANISMS OF CELL MIGRATION IN CANINE TUMOURS 56
Analytical and diagnostic validation of a flow cytometric strategy to quantify blood and marrow infiltration in dogs with large b-cell lymphoma 44
Minimal Residual Disease assessment based on IgH rearrangements and flow cytometry in canine Diffuse Large B-cell Lymphoma 39
Expression of matrix metalloproteinases, metalloproteinase inhibitors and vascular endothelial growth factor in canine mast cell tumours: preliminary results 38
Clinical spectrum of canine lymphoma with histologic correlation according to the Who classification- recognizing differences. 36
Matrix methalloproteinases and vascular endothelial growth factor in canine lymphohematopoietic malignancies 35
The role of growth factors in canine X-linked hereditary nephropathy: an animal model of progressive renal failure. 27
Espressione dell' hmw-maa nei melanomi orali canini come potenziale target terapeutico in immunoterapia. 24
Genetic heterogeneity of canine DLBCL by Oligonucleotide Array CGH. 22
Genetic heterogeneity of canine DLBCL by Oligonucleotide Array CGH. 19
VEGF e MMP-9 cross-talk: possibili biomarcatori nel linfoma canino. 17
Totale 1.922
Categoria #
all - tutte 6.300
article - articoli 4.636
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.936


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019124 0 0 0 0 0 0 0 0 0 0 67 57
2019/2020364 63 8 5 28 39 50 34 35 36 30 26 10
2020/2021237 10 12 12 10 6 32 4 17 56 18 36 24
2021/2022363 23 67 27 9 10 40 25 21 18 10 27 86
2022/2023301 50 7 1 38 65 62 4 18 36 3 13 4
2023/2024126 3 30 29 14 2 14 1 13 4 15 1 0
Totale 1.922